Cargando…
A new computerized tomography classification to evaluate response to Denosumab in giant cell tumors in the extremities
OBJECTIVES: The aim of this study was to describe the cohort of patients who have been treated with Denosumab as neoadjuvant therapy prior to surgery for aggressive giant cell tumor of bone in the extremities, to evaluate the radiological responses to Denosumab comparing Choi criteria and a newly de...
Autores principales: | Campanacci, Laura, Sambri, Andrea, Medellin, Manuel Ricardo, Cimatti, Pietro, Errani, Costantino, Donati, Davide Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Association of Orthopaedics and Traumatology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819755/ https://www.ncbi.nlm.nih.gov/pubmed/31253385 http://dx.doi.org/10.1016/j.aott.2019.05.005 |
Ejemplares similares
-
Risk factors of fracture following curettage for bone giant cell tumors of the extremities
por: Tsukamoto, Shinji, et al.
Publicado: (2022) -
Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity
por: Tsukamoto, Shinji, et al.
Publicado: (2022) -
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
por: Müller, Daniel A., et al.
Publicado: (2016) -
Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum
por: Tsukamoto, Shinji, et al.
Publicado: (2021) -
Late Local Recurrence of Bone Giant Cell Tumors Associated with an Increased Risk for Malignant Transformation
por: Tsukamoto, Shinji, et al.
Publicado: (2021)